U2BIO CO., LTD.

Otros idiomas U2Bio Co., Ltd.

Acciones

A221800

KR7221800006

Precio de cierre Korea S.E. Otros sitios de cotización 00:00:00 14/06/2024			Varia. Cinco días.	Varia. 1 de enero.
4.180 ^KRW	-0,36 %		-1,53 %	-20,83 %

2023

U2Bio Co., Ltd. ha presentado una oferta pública inicial.

CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

U2Bio Co., Ltd. has filed an IPO.	12/04/23
Chang Moo Jeon acquired 8.5% stake in U2Bio CO. LTD. from MAC Fund, L.P. (Class B), a fund managed by M-Venture Investment, Inc. for KRW 1.6 billion.	24/09/20
U2Bio CO. LTD. announced that it has received KRW 7 billion in funding	18/04/19
U2Bio CO. LTD. announced that it expects to receive KRW 7 billion in funding	12/04/19
NDS Corporation acquired additional 11.9% stake in U2Bio CO. LTD. from BSK Potential Fund 1, fund of BSK Investment for KRW 3.8 billion.	05/10/18
NDS Corporation acquired 11.85% stake in U2Bio CO. LTD. for KRW 3.8 billion.	05/10/18
An undisclosed buyer acquired 5.26% stake in U2Bio CO. LTD. from CKD Venture Fund 4 managed by CKD Venture Capital Co., Ltd. for KRW 1.1 billion.	12/07/17
U2Bio CO. LTD. announced that it has received KRW 1.5 billion in funding	10/08/16
U2Bio CO. LTD. announced that it expects to receive KRW 1.5 billion in funding	09/08/16

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Asegure y Aumente el Rendimiento de sus Inversiones con nuestro Equipo de Expertos a su lado

Asegurar mis Inversiones

fermer